Target intelligence / Profile preview

Small, Dense Low-Density Lipoprotein (sdLDL)

Target
sdLDL
Molecular classification
Lipoprotein particle subclass
01

Overview

Small, dense low-density lipoprotein (sdLDL) is a subclass of LDL particles characterized by their smaller size and higher density compared to larger LDL particles. sdLDL is considered the most atherogenic form of LDL due to its increased propensity to penetrate the arterial wall, become oxidized, and contribute to the development of atherosclerosis. Elevated levels of sdLDL are strongly associated with an increased risk for cardiovascular diseases.

Other names
Small dense LDLsd-LDLatherogenic LDL
02

Mechanism of action

Targets lipid metabolism to reduce LDL cholesterol and/or increase LDL receptor activity, or prevent cholesterol absorbtion, ultimately aiming to reduce sdLDL levels and prevent atherosclerosis.

03

Biological functions

Cholesterol transportLipid metabolism
04

Disease associations

Cardiovascular diseaseAtherosclerosisCoronary Heart DiseaseMetabolic SyndromeHyperlipidemia
05

Safety considerations

Drug-related side effects (e.g., myopathy with statins)Individual variability in response to lipid-lowering therapiesPotential for drug interactionsLong-term adherence to lifestyle modifications
06

Interacting drugs

Statins

4 more in the full profile.

07

Biomarkers

sdLDL-C levelTotal LDL-C levelTriglyceride levelApoB level

Beyond the preview

Go deeper on Small, Dense Low-Density Lipoprotein (sdLDL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small, Dense Low-Density Lipoprotein (sdLDL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call